Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$287,751,311
+$97,631,257 QoQ
Shares Held
1,133,013
+45.7% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#160
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $1,210,256,847 across 11 Drug Manufacturers - General names. JNJ ranks #2 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
373,768 | $448,308,589 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,133,013 | $287,751,311 | |
| 3 | ABBV |
AbbVie Inc.
|
619,181 | $155,810,706 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,301,674 | $132,622,455 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
657,582 | $83,078,909 | |
| 6 | MRK |
Merck & Co., Inc.
|
393,429 | $50,555,626 | |
| 7 | BIIB |
Biogen Inc.
|
186,929 | $40,387,879 | |
| 8 | AMGN |
Amgen Inc
|
18,488 | $6,694,874 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $287,751,311 | 1,133,013 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $190,120,054 | 777,778 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $147,714,908 | 713,771 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $24,304,482 | 131,078 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $66,751,750 | 437,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $76,888,565 | 463,631 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $52,739,443 | 364,676 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $77,639,704 | 479,080 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $115,771,874 | 792,090 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $23,881,311 | 150,966 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $30,997,999 | 197,767 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $46,259,930 | 297,014 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $85,876,576 | 518,829 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $82,074,360 | 529,512 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $114,761,025 | 649,652 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $135,903,268 | 831,925 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $167,739,139 | 944,956 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $175,187,424 | 988,475 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $148,917,803 | 870,508 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $153,193,732 | 948,568 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $137,242,917 | 833,088 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $141,146,080 | 858,814 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $151,071,737 | 959,917 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $142,118,763 | 954,586 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $133,145,812 | 946,781 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $126,888,731 | 967,656 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||